StockTipsArenaBeta

BUY Onesource Specialty Pharma Limited — IDBI Capital

BUYOnesource Specialty Pharma Limited
Onesource Specialty Pharma share price target & all analyst calls

byIDBI CapitalHorizon: 1–3 months29 May 2026via IDBI Capital Research Calls Telegram

Entry₹1,842Stated
Target₹2,000
Total upside +8.58% (call closed)
Stop loss₹1,755-4.72% risk
Exit₹1,7558 Jun 2026, 12:06 pm
Stop-loss hit-4.72%
Follow IDBI Capital for new calls(32% target hit, 187 closed calls)Get alertsWatch ONESOURCE for new buy/sell callsGet alertsSee 42 active Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 23 Oct, 5:28 pm IST
3 supporting1 neutral0 opposing
Supports the BUY call (3)

Onesource Specialty Pharma Limited announced its FY26 results with strong Q4 performance and reaffirmed its FY28 guidance in a press release.

NSE · Press Release·13 May · 4w ago

(opens in new tab)

1 advisor has an active long-term BUY call on this stock

Advisor consensus · adjacent horizon·13 Nov · 7mo ago

Neutral / worth noting (1)

Onesource Specialty Pharma Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.

NSE · Outcome of Board Meeting·13 May · 4w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Onesource Specialty Pharma

All analyst calls on Onesource Specialty Pharma

More from IDBI Capital

Every call and its outcome